BackVor Biopharma Overview

Vor Biopharma Accounts Payable

Vor Biopharma's accounts payable is $1M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.04M
72.05% YoYΔ $-2.69M vs prior year quarter

Peer average

Loading

Vor Biopharma Accounts Payable History

Loading

Vor Biopharma vs. peers: Accounts Payable Comparison

Loading

Vor Biopharma Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vor Biopharma (VOR) FAQ

As of the most recent data (March 2026), VOR shows a accounts payable of $1M. That compares with $3.7M in the prior-year period — down 72.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VOR's accounts payable is now $1M (was $3.7M) — a 72.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Vor Biopharma is outperforming or lagging.

Tracking VOR's accounts payable over time shows whether Vor Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1M That compares with $3.7M in the prior-year period — down 72.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Vor Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1M) with ownership activity and broader fundamentals.

Vor Biopharma's accounts payable is $1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.